About Lindsay Rosenwald, M.D.
Form D filings for Urica Therapeutics in 2023 list Lindsay Rosenwald, M.D. as director.
Lindsay Rosenwald, M.D. first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Lindsay Rosenwald, M.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Lindsay Rosenwald, M.D. works with at each company, as listed on that company's latest Form D.
Urica Therapeutics, Inc. · Form D, Jan 5, 2023
RZ
Raymond Zheng
Executive officer and director
JD
Jay Kranzler, M.D., Ph.D.
Executive officer and director
MW
Michael Weiss
Director
VD
Vibeke Strand, M.D.
Director